Cargando…

Strategies to Optimise Oncolytic Viral Therapies: The Role of Natural Killer Cells

Oncolytic viruses (OVs) are an emerging class of anti-cancer agents that replicate selectively within malignant cells and generate potent immune responses. Their potential efficacy has been shown in clinical trials, with talimogene laherparepvec (T-VEC or IMLYGIC(®)) now approved both in the United...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leung, Elaine Y. L., McNeish, Iain A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402671/ https://www.ncbi.nlm.nih.gov/pubmed/34452316 http://dx.doi.org/10.3390/v13081450

Ejemplares similares

NK Cells Augment Oncolytic Adenovirus Cytotoxicity in Ovarian Cancer
por: Leung, Elaine Y.L., et al.
Publicado: (2020)

Emerging role of Natural killer cells in oncolytic virotherapy
por: Bhat, Rauf, et al.
Publicado: (2015)

Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer
por: Ingemarsdotter, C K, et al.
Publicado: (2010)

Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer Cells
por: Alvarez-Breckenridge, Christopher A., et al.
Publicado: (2012)

p21 promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker
por: Flak, Magdalena B, et al.
Publicado: (2010)

Dendritic cells and natural killer cells: The road to a successful oncolytic virotherapy
por: Ghasemi, Matin, et al.
Publicado: (2023)

Oncolytic Viral Therapy for Mesothelioma
por: Pease, Daniel F., et al.
Publicado: (2017)

Practical guidance for the management of side effects during rucaparib therapy in a multidisciplinary UK setting
por: Tookman, Laura, et al.
Publicado: (2020)

Natural Killer Cells in Viral Hepatitis
por: Rehermann, Barbara
Publicado: (2015)

Molecular imaging of oncolytic viral therapy
por: Haddad, Dana, et al.
Publicado: (2015)

Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors
por: Coughlan, Lynda, et al.
Publicado: (2010)

Viral Evasion of Natural Killer Cell Activation
por: Ma, Yi, et al.
Publicado: (2016)

Viral Infection of Human Natural Killer Cells
por: van Erp, Elisabeth A., et al.
Publicado: (2019)

Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
por: Abudoureyimu, Mubalake, et al.
Publicado: (2019)

Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer
por: Iyoda, Tomonori, et al.
Publicado: (2023)

Patient’s Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers
por: Messaoudene, Meriem, et al.
Publicado: (2017)

The role of NK cells in oncolytic viral therapy: a focus on hepatocellular carcinoma
por: Warricker, Frazer, et al.
Publicado: (2021)

The potential and challenges of targeting MTAP-negative cancers beyond synthetic lethality
por: Bray, Chandler, et al.
Publicado: (2023)

Update on oncolytic viral therapy – targeting angiogenesis
por: Tysome, James R, et al.
Publicado: (2013)

Oncolytic viral therapy: targeting cancer stem cells
por: Smith, Tyrel T, et al.
Publicado: (2014)

Roles of Natural Killer T Cells and Natural Killer Cells in Kidney Injury
por: Uchida, Takahiro, et al.
Publicado: (2019)

Corrigendum: Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
por: Abudoureyimu, Mubalake, et al.
Publicado: (2020)

The Emerging Role of Interleukin 1β (IL-1β) in Cancer Cachexia
por: Laird, Barry J., et al.
Publicado: (2021)

CD40 ligand induced cytotoxicity in carcinoma cells is enhanced by inhibition of metalloproteinase cleavage and delivery via a conditionally-replicating adenovirus
por: Elmetwali, Taha, et al.
Publicado: (2010)

APOBEC3 Mediates Resistance to Oncolytic Viral Therapy
por: Huff, Amanda L., et al.
Publicado: (2018)

Mechanisms of diarrhoea
por: Booth, I.W., et al.
Publicado: (1993)

Control of Viral Infection by Natural Killer Cell Inhibitory Receptors
por: Parikh, Bijal A., et al.
Publicado: (2020)

The Influence of Hepatitis C Viral Loads on Natural Killer Cell Function
por: Collister, Mark, et al.
Publicado: (2019)

Novel oncolytic viral therapies in patients with thoracic malignancies
por: Ahmad, Zeeshan, et al.
Publicado: (2016)

Oncolytic Viral Therapy for Glioma by Recombinant Sindbis Virus
por: Sun, Kangyixin, et al.
Publicado: (2023)

Safe administration of chemotherapy in mast cell activation syndrome
por: Lythgoe, MP, et al.
Publicado: (2020)

Regulation of K(Ca)2.3 and endothelium-dependent hyperpolarization (EDH) in the rat middle cerebral artery: the role of lipoxygenase metabolites and isoprostanes
por: Gauthier, Kathryn M., et al.
Publicado: (2014)

The current status of oncolytic viral therapy for head and neck cancer
por: Old, Matthew O., et al.
Publicado: (2016)

Proliferative Role of Kv11 Channels in Murine Arteries
por: Barrese, Vincenzo, et al.
Publicado: (2017)

The role of natural killer cell in gastrointestinal cancer: killer or helper
por: Wang, Feixue, et al.
Publicado: (2020)

A New Role for Vitamin D: The Enhancement of Oncolytic Viral Therapy in Pancreatic Cancer
por: LaRocca, Christopher J., et al.
Publicado: (2018)

Editorial: Rising stars in vascular physiology: 2022
por: Tulis, David A., et al.
Publicado: (2023)

Overview of Strategies to Improve Therapy against Tumors Using Natural Killer Cell
por: Yang, Chaopin, et al.
Publicado: (2020)

Natural killer cell-based therapies
por: Romagné, François, et al.
Publicado: (2011)

Allogeneic natural killer cell therapy
por: Berrien-Elliott, Melissa M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_58ckgsc2knu425hba7dk4d8cqd